Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Buy
671
+36
+6% +$769 ﹤0.01% 1870
2026
Q1
$12.8K Buy
635
+57
+10% +$1.27K ﹤0.01% 1765
2025
Q4
$11.1K Sell
578
-34
-6% -$715 ﹤0.01% 1790
2025
Q3
$14.7K Buy
612
+99
+19% +$2.31K ﹤0.01% 1539
2025
Q2
$9.98K Buy
513
+331
+182% +$4.89K ﹤0.01% 1608
2025
Q1
$2.34K Sell
182
-292
-62% -$4.69K ﹤0.01% 1944
2024
Q4
$8.17K Buy
474
+124
+35% +$2.48K ﹤0.01% 1534
2024
Q3
$7.9K Buy
350
+206
+143% +$4.71K ﹤0.01% 1567
2024
Q2
$3.56K Buy
144
+68
+89% +$1.93K ﹤0.01% 1558
2024
Q1
$2.5K Sell
76
-100
-57% -$3.4K ﹤0.01% 1480
2023
Q4
$6.4K Hold
176
﹤0.01% 1383
2023
Q3
$6.46K Hold
176
﹤0.01% 1370
2023
Q2
$6.74K Hold
176
﹤0.01% 1372
2023
Q1
$7.21K Hold
176
﹤0.01% 1359
2022
Q4
$6K Hold
176
﹤0.01% 1395
2022
Q3
$5K Sell
176
-26
-13% -$843 ﹤0.01% 1452
2022
Q2
$6K Sell
202
-14
-6% -$470 ﹤0.01% 1516
2022
Q1
$9K Hold
216
﹤0.01% 1500
2021
Q4
$10K Buy
+216
New +$9.69K ﹤0.01% 1441

Other funds holding ADNT

UMB Bank's ADNT Position: Q2 2026 in Review

UMB Bank increased its Adient (ADNT) stake by 5.7% in Q2 2026, buying an estimated $769 and bringing the position to 671 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

UMB Bank first reported a position in ADNT in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.7K in Q3 2025. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • UMB Bank held 671 shares of Adient worth $12.3K as of Q2 2026.
  • UMB Bank bought 36 Adient shares in Q2 2026, an estimated $769.
  • Adient made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1870 holding.
  • UMB Bank first reported a position in Adient in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Adient position peaked at $14.7K in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.